The conflicted finding regarding the impact of metformin on HNSCC prognosis may be attributed to discrepancies in the HPV status of patients; INHBA enrichment in HPV-negative tumors, as shown in the current study, possibly renders the impact of metformin HPV-dependent. The gene discussed is INHBA; the disease is head and neck squamous cell carcinoma.